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Blood-brain barrier
The BBB is a regulatory interface between the peripheral circulation and the CNS [30] . The BBB regulates the passage of blood-borne substances and cells into the brain and thus maintains the homeostasis of the neural microenvironment that is crucial for normal neuronal activity and function [1] . It is a specialized system which has a unique role in the protection of the brain from toxic substances in blood and filters harmful compounds from the brain back to the bloodstream. The BBB allows the passage of water, some gases, and lipid-soluble molecules by passive diffusion, as well as the selective transport of molecules such as glucose and amino acids [1] . The unique property of the BBB is primarily determined by the presence of endothelial junctional complexes made up of adherens junctions (AJs) and highly specialized tight junctions (TJs). Apart from the presence of specialized TJs, other unique properties of the BBB are the absence of fenestrae, reduced level of fluidphase endocytosis and asymmetrically localized enzymes [2] . An intact BBB prevents the transfer of macromolecules to the brain tissue. The penetration of substances into the brain, also avoids enzymatic barriers, which are composed of enzyme systems located in the walls of the cerebral blood vessels (e. g. aminopeptidase or monoaminooxidase).
Cells of blood-brain barrier
The BBB is formed by the brain microvascular endothelial cells (BMECs) that line the cerebral microvessels. , junctional adhesion molecules (JAM) [34] and the recently discovered endothelial cell-selective adhesion molecule [36] (Fig. 2) .
Traversal of the BBB by pathogens
One of the basic steps in the invasion of a pathogen into the CNS is crossing through the BBB. [35] In recent years, the interest of researchers has been aimed at the cell signaling pathway, which is triggered after infection in the cells of the NVU. Neuroinvasive pathogens infect host cells through ligand-receptor interactions.
Pathogens ligands interact with receptors, which are bound to the brain microvascular endothelial cells. These interactions are described in a variety of pathogens ( Table 1) .
Transversal of the BBB by Borrelia
Lyme disease is an infectious bacterial disease caused by the microaerophilic spirochete Borreliella species, which affects the peripheral and CNS. It is one of the most common tick-borne diseases in Europe and in North America [49] . Neurological complications, collectively termed neuroborreliosis, can occur in up to 15 % of untreated patients.
Typical symptoms of the damage of the CNS are headache, flu-like symptoms, fatigue, memory loss and depression. In the case of the infection of the peripheral nervous system, typical symptoms are the malfunction of the facial nerve and muscle weakness [49] .
Several bacteria express their own proteases that digest the extracellular matrix in order to invade tissues, however, B. burgdorferi appear to utilize the fibrinolytic system of the host to disseminate [7] . B. burgdorferi does not produce any collagenase, elastase, hyaluronidase or plasminogen activators [31] . It is a well-known fact that Borreliella can bind plasminogen and promotes degradation of the ECM [7] . On the other hand, fibrinolytic system also initiates other proteases, including the matrix metalloproteinases (MMPs), which are predicted to be essential for borrelial invasion into the brain [16] . Plasminogen bound on the bacterial surface can be converted into plasmin by host activators [4] . Plasmin bound to the surface of the bacterial cell is stabilized and protected against inactivation by α1-and α2-antiplasmin [42] . Borreliella induces the expression and secretion of the urokinase-type plasminogen activa- Another alternative, which is used by Borreliella to translocate through the BBB, is the exploitation of CD40.
OspA of Borreliella binds CD40 expressed on brain endothelial cells of the host. This binding induces the expression 
